SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
SIOX
Delisted
SIOX was delisted on the 22nd of March, 2023.
41 hedge funds and large institutions have $8.53M invested in Sio Gene Therapies Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
–
Holders Change %
0%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
14
Closed
8
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$1K
Top Buyers
1 |
TVWM
Tower View Wealth Management
Shorewood,
Wisconsin
|
+$1.09M |
2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$1.08M |
3 |
NM
Newtyn Management
New York
|
+$510K |
4 |
Jane Street
New York
|
+$33K |
5 |
UBS Group
Zurich,
Switzerland
|
+$20K |
Top Sellers
1 |
PM
Prosight Management
Dallas,
Texas
|
-$449K |
2 |
CIA
Cladis Investment Advisory
Billings,
Montana
|
-$183K |
3 |
Citadel Advisors
Miami,
Florida
|
-$139K |
4 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$60K |
5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$57.3K |